Novel Suppressive Effects of Ketotifen on Migration and Invasion of MDA-MB-231 and HT-1080 Cancer Cells.
10.4062/biomolther.2014.081
- Author:
Hyun Ji KIM
1
;
Mi Kyung PARK
;
Soo Youl KIM
;
Chang Hoon LEE
Author Information
1. BK21PLUS R-FIND Team, College of Pharmacy, Dongguk University, Seoul 100-715, Republic of Korea. uatheone@dongguk.edu
- Publication Type:Original Article
- Keywords:
Ketotifen;
Migration;
Invasion;
MDA-MB-231;
HT-1080
- MeSH:
Blotting, Western;
Breast Neoplasms;
Cell Movement;
Extracellular Matrix;
Fibrosarcoma;
Ketotifen*;
Matrix Metalloproteinase 9;
Mortality;
Neoplasm Metastasis
- From:Biomolecules & Therapeutics
2014;22(6):540-546
- CountryRepublic of Korea
- Language:English
-
Abstract:
The high mortality rates associated with cancer reflect the metastatic spread of tumor cells from the site of their origin. Metastasis, in fact, is the cause of 90% of cancer deaths. Therefore, considerable effort is being made to inhibit metastasis. In the present study, we screened ketotifen for anti-migratory and anti-invasive activities against MDA-MB-231 breast cancer and HT-1080 fibrosarcoma cancer cells. Cancer cell migration and invasion were measured using multi-well chambers. Additionally, western blots were used to examine the effects of ketotifen on the expressions of CDC42, Rho, Rac, and matrix metalloproteinase 9 (MMP-9). The results showed that ketotifen dose-dependently suppressed the migration and invasion of MDA-MB-231 and HT-1080 cells. Ketotifen also suppressed the expressions of CDC42, Rac, and Rho, which, significantly, are involved in MDA-MB-231 and HT-1080 cancer cell migration. Moreover, ketotifen suppressed the expression and activity of MMP-9, which is involved in degradation of the extracellular matrix leading to invasion. The overall data suggested that ketotifen suppresses the migration and invasion of MDA-MB-231 and HT-1080 cancer cells via inhibition of CDC42, Rac, Rho, and MMP-9 expression.
